NCT00003222 arm group 390d0b91d24824a4d8b2c9558c63f0f3 [clinicaltrials_resource:NCT00003222/arm-group/390d0b91d24824a4d8b2c9558c63f0f3]
tyrosinase peptide [clinicaltrials_resource:2cd7697c4be62967125d5b12278a72ca]aldesleukin [clinicaltrials_resource:57a158e046be060439f3e1a54bfa73ba]gp100 antigen [clinicaltrials_resource:83c08bc74548355c29161a584375fcd7]tetanus peptide melanoma vaccine [clinicaltrials_resource:b093fbd1e10f2da513c85447c43fa220]incomplete Freund's adjuvant [clinicaltrials_resource:dbddd4d55226c4de9af281754ba9982b]clinicaltrials:NCT00003222
arm group [clinicaltrials_vocabulary:arm-group]
NCT00003222 arm group 390d0b91d24824a4d8b2c9558c63f0f3 [clinicaltrials_resource:NCT00003222/arm-group/390d0b91d24824a4d8b2c9558c63f0f3]
Bio2RDF identifier
NCT00003222/arm-group/390d0b91d24824a4d8b2c9558c63f0f3
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltri ...... 0d0b91d24824a4d8b2c9558c63f0f3
description [clinicaltrials_vocabulary:description]
4 melanoma peptides pulsed on monocyte-derived dendritic cells
identifier
clinicaltrials_resource:NCT00003222/arm-group/390d0b91d24824a4d8b2c9558c63f0f3
title
NCT00003222 arm group 390d0b91d24824a4d8b2c9558c63f0f3
@en
type
label
NCT00003222 arm group 390d0b91 ...... d0b91d24824a4d8b2c9558c63f0f3]
@en